BugBiome Secures £310K Pre-Seed Funding to Advance Microbial Pest-Control Solutions

bugbiome

Biotech start‑up BugBiome has secured a £310,000 pre‑seed investment round led by Cambridge Angels and Discovery Park Ventures, marking a significant step forward for the Cambridge‑based company in its mission to bring nature‑based pest‑control solutions to agriculture and human health. The investment also underpins a matched £330,000 Engineering Biology Grant from Innovate UK, enabling BugBiome to accelerate its research into microbe‑derived pest protection, notably targeting aphids, whose damage to crop yields remains a major global challenge.

Founded in 2021 by Dr Alicia Showering (CEO) and Dr Chris Mosedale (CTO), BugBiome has built a proprietary insect‑behavioural screening platform that identifies microbial consortia capable of deterring pests without harming beneficial insects. The company’s goal is to replace synthetic chemical pesticides with sustainable microbial alternatives that maintain ecosystem health while protecting crops. The recent funding will support the development of this pipeline, expand the team, advance laboratory validation and pave the way for field trials in targeted crop applications.

The funding package also carries strategic governance implications: Emma Palmer Foster of Discovery Park Ventures and James Thomas of Cambridge Angels are joining the board as investor‑directors, offering the company access to both funding networks and domain expertise. The combination of private investment and a matched government grant provides BugBiome with an extended runway at a timely moment in the ag‑biotech sector, where demand for eco‑friendly pest‑control solutions is gaining momentum.

In addition to the investment round, BugBiome was previously selected as the winner of the “Discovery Spark” life‑science business support programme at the GIANT Health conference in December 2023, earning a business‑support package worth over £100,000 including a year of free laboratory space at Discovery Park and £50,000 investment from Discovery Park Ventures. That earlier recognition underscored investor confidence in the company’s promise and execution.

BugBiome’s co‑founder Dr Showering explained that the team is “delighted to announce a successful pre‑seed funding round … this investment enables our non‑dilutive Innovate UK grant and will help us to advance our pipeline of innovative microbial solutions for pest protection, offering an effective alternative to chemicals.” The company emphasises that its technology takes a broader view of insect behaviour, detecting multiple behavioural modes in pests to identify microbes with diverse mechanisms of action‑—a strategy aimed at maintaining efficacy and delaying resistance development in pest populations.

The strategic focus of BugBiome centers on applying these microbial discoveries to real‑world agriculture, starting with aphid‑control solutions, and eventually branching into additional crops and pest types. Given that pests and diseases account for an estimated 30 – 40 percent of global crop losses, the addressable market for more effective, environmentally‑sensitive control methods is considerable. BugBiome’s approach—minimising harm to pollinators and beneficial insects—aligns with growing regulatory and consumer pressures for sustainable agriculture.

As BugBiome enters this next phase of development, the freshly secured funding and grant support provide key resources to scale its platform, undertake more advanced testing, and build partnerships with farmers, crop‑protection companies and regulatory bodies. The combination of state‑backed grant funding and private early‑stage investment positions the company well to navigate the “valley of death” that often challenges deep‑tech ag‑biotech start‑ups.

Looking ahead, the company aims to move toward proof‑of‑concept field trials and commercial partnerships in the coming months. Should BugBiome succeed in deploying its microbial platforms at scale, it may contribute meaningfully to the transformation of crop‑protection technology—offering farmers new tools that protect yields, safeguard ecological networks, and reduce dependence on synthetic chemistry for both agricultural and human‑health pest‑control applications.

Share this:

Related Articles